Alkem Laboratories Limited Alkem Laboratories Limited

Alkem Laboratories Limited

ALKEM

Rang în acțiuni #2812
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Preț acțiune
$55.19
Capitalizare de piață
$6.60B
Schimbare (1 zi)
-0.06%
Schimbare (1 an)
-12.43%
Țară
IN
Tranzacționează Alkem Laboratories Limited (ALKEM)

Categorie

Healthcare
Raport P/B pentru Alkem Laboratories Limited (ALKEM)
Raport P/B la data de October 2026 TTM: 4.31
Conform celor mai recente rapoarte financiare și prețului acțiunilor Alkem Laboratories Limited, raportul P/B actual (TTM) este 4.31. La sfârșitul anului 2024, compania avea un P/B de 5.81.
Istoricul raportului P/B pentru Alkem Laboratories Limited din 2010 până în 2026
Raport P/B la sfârșitul fiecărui an
An Raport P/B Schimbă
2026 (TTM) 4.31 -10.49%
2025 4.82 -16.94%
2024 5.81 29.38%
2023 4.49 -10.43%
2022 5.01 11.63%
2021 4.49 -0.54%
2020 4.51 17.52%
2019 3.84 -18.59%
2018 4.72 -20.04%
2017 5.90 34.33%
2016 4.39 -20.25%
2015 5.51 -11.47%
2014 6.22 -10.59%
2013 6.96 -19.73%
2012 8.67 -25.08%
2011 11.57 -15.57%
2010 13.71 0.00%
Raport P/B pentru companii similare sau competitoare